US Broker Ratings

Merck & Company, Inc. (MRK) Stock Analysis: Unveiling the 6.92% Potential Upside with Strong Buy Ratings

Merck & Company, Inc. (NYSE: MRK), a stalwart in the healthcare sector, has long been a focal point for investors seeking stability and growth in the pharmaceutical industry. With a..

AbbVie Inc. (ABBV) Stock Analysis: Evaluating the Strong Dividend Yield and Potential 7.73% Upside

AbbVie Inc. (NYSE: ABBV), a leading player in the healthcare sector, has consistently captured investor attention with its robust market presence and innovative drug portfolio. With a market capitalization of..

AngioDynamics, Inc. (ANGO) Stock Analysis: Exploring a 41.95% Upside Potential in the Healthcare Sector

AngioDynamics, Inc. (NASDAQ: ANGO), a prominent player in the medical instruments and supplies industry, is drawing attention from investors with its intriguing blend of innovative technology and potential for significant..

Atai Beckley N.V. (ATAI) Stock Analysis: High Growth Potential with 172.73% Upside Amid Innovative Mental Health Therapies

Atai Beckley N.V. (ATAI), a Netherlands-based biotechnology firm specializing in mental health treatments, is capturing investor attention with its innovative approaches and substantial growth potential. With a current market capitalization..

Oruka Therapeutics, Inc. (ORKA) Stock Analysis: Unpacking the 51.63% Potential Upside in Biotechnology

Oruka Therapeutics, Inc. (NASDAQ: ORKA) is emerging as a compelling player in the biotechnology sector, attracting attention with a market capitalization of $1.5 billion. The company, headquartered in Menlo Park,..

Inventiva S.A. (IVA): Biotech Innovator with a 266% Potential Upside – What Investors Need to Know

Investors with an eye on the healthcare sector might want to take a closer look at Inventiva S.A. – American Depositary Shares (IVA), a biopharmaceutical company that is making waves..

Cross Country Healthcare, Inc. (CCRN): Investor Outlook with Nearly 89% Potential Upside

Cross Country Healthcare, Inc. (NASDAQ: CCRN) operates at the intersection of healthcare and human resources, providing essential staffing solutions to a variety of medical facilities across the United States. With..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Navigating Challenges with a 25.9% Revenue Growth

Sonida Senior Living, Inc. (SNDA) is a prominent player in the healthcare sector, specifically within the medical care facilities industry, with a focus on senior housing communities across the United..

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: An 79.44% Upside Potential in the Biotech Sector

Rapport Therapeutics, Inc. (RAPP), a clinical-stage biopharmaceutical firm, is carving out a notable position within the biotechnology sector, focusing on developing innovative small molecule medicines for central nervous system (CNS)..

Sana Biotechnology, Inc. (SANA) Stock Analysis: Exploring a 65.47% Upside Potential in the Biotech Sector

Sana Biotechnology, Inc. (NASDAQ: SANA) is rapidly gaining traction within the healthcare sector, specifically in biotechnology, where its innovative approach to cell engineering has captured the attention of investors. With..

Talkspace, Inc. (TALK) Investor Outlook: A Promising 60% Upside Potential

Talkspace, Inc. (NASDAQ: TALK), a leading player in the healthcare sector, has captured investor attention with its innovative approach to delivering mental health services. With a market capitalization of $530.87..

Bioventus Inc. (BVS) Stock Analysis: A Promising 96.85% Upside for Investors

Bioventus Inc. (NASDAQ: BVS), a key player in the healthcare sector, particularly within the medical devices industry, is making waves with its potential for significant stock appreciation. The company, which..

Maze Therapeutics, Inc. (MAZE): Investor Outlook on a Biotech Innovator with a Strong Buy Consensus

Maze Therapeutics, Inc. (NASDAQ: MAZE), a promising player in the biotechnology sector, has been attracting significant attention from investors as it navigates the complex landscape of precision medicine. Headquartered in..

Emergent BioSolutions Inc. (EBS) Stock Analysis: Analyst Ratings Indicate Potential 12% Upside

Emergent BioSolutions Inc. (NYSE: EBS) is making waves in the healthcare sector as it navigates a complex landscape of public health preparedness. Founded in 1998 and headquartered in Gaithersburg, Maryland,..

Prothena Corporation plc (PRTA) Stock Report: Exploring an 82% Potential Upside for Biotech Investors

Prothena Corporation plc (NASDAQ: PRTA), a biotechnology company based in Dublin, Ireland, is capturing the attention of investors with its promising pipeline and significant potential upside. Operating in the healthcare..

PureTech Health plc (PRTC) Stock Analysis: Exploring a 542.70% Revenue Surge in the Biotech Arena

PureTech Health plc (NASDAQ: PRTC), a dynamic player in the biotechnology sector, is capturing investor attention with an impressive revenue growth rate of 542.70%. Operating out of Boston, Massachusetts, this..

EyePoint Pharmaceuticals, Inc. (EYPT) Stock Analysis: Exploring 112% Potential Upside with Innovative Retinal Treatments

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a promising player in the biotechnology sector, is capturing attention with its potential to revolutionize treatment for serious retinal diseases. With a market capitalization of..

Orthofix Medical Inc. (OFIX) Stock Analysis: A 43% Potential Upside in the Medical Devices Sector

Orthofix Medical Inc. (NASDAQ: OFIX) stands out in the healthcare sector, particularly within the medical devices industry, where it has carved out a niche through its innovative solutions for spinal..

Kamada Ltd. (KMDA) Stock Analysis: A Promising Growth Outlook with Over 107% Potential Upside

Kamada Ltd. (NASDAQ: KMDA) is drawing attention from the investment community with its notable growth prospects and substantial potential upside. As a key player in the healthcare sector, specifically within..

Tilray Brands, Inc. (TLRY) Stock Analysis: Unpacking a Potential 147% Upside

Tilray Brands, Inc. (NASDAQ: TLRY) stands out in the healthcare sector as a dynamic player in the specialty and generic drug manufacturing niche. Based in Leamington, Canada, Tilray has crafted..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds